Two pharmacists discuss complexities patients face when starting specialty medications and predict how CVS’s restructuring and reduced specialty pharmacy lock-in may improve affordability and choice.
Mark Schneider, PharmD
Advertisement
Articles by Mark Schneider, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
The Most Accessible Healthcare Professional—But Accessible to Whom?
4
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
5